SCHEMBL27453710

SCHEMBL27453710

O=C1CCC(N2CCc3c(N4CCN(OC(=O)c5ccccc5)CC4)cccc32)C(=O)N1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 18/20 0.41
▸ DDB1 Q16531 7/20 0.41
▸ IKZF3 Q9UKT9 8/20 0.40
▸ CSNK1A1 P48729 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TNF P01375 2/20 0.38
▸ IL1B P01584 2/20 0.38
▸ IKZF1 Q13422 2/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ CHRM2 P08172 1/20 0.37
▸ OPRM1 P35372 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ TBXA2R P21731 1/20 0.37
▸ HPGDS O60760 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27453719 0.81 CRBN (0.44) CRBNDDB1IKZF3ALDH1A1KDM4E
SCHEMBL27453731 0.81 CRBN (0.44) CRBNDDB1IKZF3ALDH1A1KDM4E
SCHEMBL26930886 0.81 CRBN (0.46) CRBNDDB1IKZF3CSNK1A1ALDH1A1
SCHEMBL26930503 0.79 CRBN (0.48) CRBNDDB1IKZF3ALDH1A1KDM4E
SCHEMBL26930466 0.79 CRBN (0.48) CRBNDDB1IKZF3ALDH1A1KDM4E
SCHEMBL30659363 0.79 CRBN (0.48) CRBNDDB1IKZF3ALDH1A1KDM4E
SCHEMBL27454822 0.79 CRBN (0.47) CRBNDDB1IKZF3ALDH1A1KDM4E
SCHEMBL30796394 0.79 TMEM97 (0.49) CRBNDDB1IKZF3GAA
SCHEMBL26930449 0.78 CRBN (0.46) CRBNDDB1IKZF3ALDH1A1KDM4E
SCHEMBL26954254 0.78 CRBN (0.52) CRBNDDB1IKZF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback